SOTERA HEALTH COMPANY Unrealized Gain (Loss) on Derivatives
SOTERA HEALTH COMPANY (SHC) reported Unrealized Gain (Loss) on Derivatives of -$682.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2026-08-06
- SOTERA HEALTH COMPANY unrealized gain (loss) on derivatives for the quarter ending 2026-06-30 was $512.00K, a 85.77% decline year-over-year.
- SOTERA HEALTH COMPANY unrealized gain (loss) on derivatives for the quarter ending 2026-03-31 was -$1.19M.
- SOTERA HEALTH COMPANY unrealized gain (loss) on derivatives for the quarter ending 2025-12-31 was $258.00K.
- SOTERA HEALTH COMPANY unrealized gain (loss) on derivatives for the quarter ending 2025-09-30 was -$1.39M, a 218.31% decline year-over-year.
- SOTERA HEALTH COMPANY unrealized gain (loss) on derivatives for fiscal 2025 was $863.00K.
- SOTERA HEALTH COMPANY unrealized gain (loss) on derivatives for fiscal 2024 was -$2.21M, a 235.19% decline from fiscal 2023.
- SOTERA HEALTH COMPANY unrealized gain (loss) on derivatives for fiscal 2023 was $1.64M.
- SOTERA HEALTH COMPANY unrealized gain (loss) on derivatives for fiscal 2022 was -$2.98M, a 349.12% decline from fiscal 2021.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|
| 2026-06-30 | $512.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$682.00K 10-Q · filed 2026-08-06 | -$424.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.81M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$1.19M 10-Q · filed 2026-05-05 | -$936.00K derived: sum of 2 quarters · filed 2026-05-05 | -$2.33M derived: sum of 3 quarters · filed 2026-05-05 | $1.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $258.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.13M derived: sum of 2 quarters · filed 2026-02-24 | $2.47M derived: sum of 3 quarters · filed 2026-08-06 | $863.00K 10-K · filed 2026-02-24 |
| 2025-09-30 | -$1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.21M derived: sum of 2 quarters · filed 2026-08-06 | $605.00K 10-Q · filed 2025-11-04 | -$1.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $3.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.99M 10-Q · filed 2026-08-06 | $357.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.53M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.60M 10-Q · filed 2026-05-05 | -$3.24M derived: sum of 2 quarters · filed 2026-05-05 | -$2.07M derived: sum of 3 quarters · filed 2026-05-05 | -$1.98M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$463.00K derived: sum of 2 quarters · filed 2026-02-24 | -$380.00K derived: sum of 3 quarters · filed 2026-02-24 | -$2.21M 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.26M derived: sum of 2 quarters · filed 2025-11-04 | -$576.00K 10-Q · filed 2025-11-04 | $2.15M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$1.75M 10-Q · filed 2025-08-08 | $974.00K derived: sum of 3 quarters · filed 2026-02-24 | -$860.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$1.83M 10-Q · filed 2025-05-01 | $891.00K derived: sum of 2 quarters · filed 2026-02-24 | -$943.00K derived: sum of 3 quarters · filed 2026-02-24 | $31.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $890.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.86M derived: sum of 3 quarters · filed 2026-02-24 | $1.64M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$860.00K derived: sum of 2 quarters · filed 2024-11-05 | -$1.09M 10-Q · filed 2024-11-05 | -$8.39M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $974.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $747.00K 10-Q · filed 2024-08-05 | -$6.55M derived: sum of 3 quarters · filed 2025-02-27 | -$10.26M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$227.00K 10-Q · filed 2024-05-02 | -$7.53M derived: sum of 2 quarters · filed 2025-02-27 | -$11.23M derived: sum of 3 quarters · filed 2025-02-27 | -$10.57M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$11.01M derived: sum of 2 quarters · filed 2025-02-27 | -$10.34M derived: sum of 3 quarters · filed 2025-02-27 | -$2.98M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$3.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$3.04M derived: sum of 2 quarters · filed 2023-11-01 | $4.32M 10-Q · filed 2023-11-01 | $5.09M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $665.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $8.03M 10-Q · filed 2023-08-03 | $8.80M derived: sum of 3 quarters · filed 2024-02-27 | |
| 2022-03-31 | $7.36M 10-Q · filed 2023-05-03 | $8.13M derived: sum of 2 quarters · filed 2024-02-27 | ||
| 2021-12-31 | $771.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.20M 10-K · filed 2024-02-27 | ||
| 2021-09-30 | $424.00K 10-Q · filed 2022-11-02 | |||
| 2020-12-31 | $3.07M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |